Sherrie Randall

Sherrie Randall serves as a key procurement professional within the CDC Office of Acquisition Services, supporting the agency’s mission to safeguard public health through strategic acquisition of scientific and technical services. She manages a portfolio of complex contracts focused on laboratory diagnostics, biomedical research, and data-driven public health operations, ensuring timely access to mission-critical capabilities. Her work directly enables the CDC’s response to infectious disease threats by facilitating the procurement of advanced diagnostic tools, epidemiological analytics platforms, and high-throughput sequencing infrastructure. Randall specializes in engineering and life sciences R&D acquisitions, aligning contracting strategies with federal public health priorities and regulatory compliance frameworks. She maintains sustained working relationships with leading contractors including General Dynamics Information Technology, GlaxoSmithKline, MRIGLOBAL, and Cepheid, partnering with organizations capable of delivering high-complexity scientific services and diagnostic technologies. These vendor relationships are built on technical excellence, regulatory adherence, and the ability to scale operations under time-sensitive public health emergencies. Randall collaborates closely with technical stakeholders to ensure contract requirements reflect evolving scientific standards and operational needs in biosurveillance and clinical research. Randall’s procurement portfolio reflects a strong preference for full and open competition, with 100% of awards issued under no set-aside classifications. This approach prioritizes access to the broadest pool of qualified technical experts and established research institutions, ensuring the CDC can rapidly deploy the most capable solutions during public health crises without socioeconomic restrictions. Her primary procurement focus lies in NAICS 541330 (Engineering Services) and 541715 (Research and Development in the Physical, Engineering, and Life Sciences), emphasizing contract vehicles for diagnostic assay development, laboratory automation, bioinformatics, and epidemiological modeling. She consistently procures high-specification scientific equipment, validated analytical software, and outsourced R&D services critical to national infectious disease surveillance and response.